Cargando…

P-147: COVID-19, impact of vaccination in myeloma patients

BACKGROUND: The worldwide COVID-19 pandemic represents an unprecedented crisis that affects the entire medical community, and appears to be a devastating infection in patients with hematological disorders, including myeloma (MM). Vaccination is therefore crucial in this population. Seroconversion af...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoornaert, Ellen, Dachy, François, Hansenne, Amandine, Lagneaux, Eugénie, Gruson, Damien, Bailly, Sarah, Vekemans, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580186/ http://dx.doi.org/10.1016/S2152-2650(21)02274-6

Ejemplares similares

COVID-19: impact of vaccination in myeloma patients
por: Hoornaert, E., et al.
Publicado: (2022)

P147: Assessing the thoroughness of hand hygiene: “To see is to believe”
por: Chen, Y-C, et al.
Publicado: (2013)

P-149: Immunogenicity of SARS-CoV-2 vaccine in patients with multiple myeloma
por: Malard, Florent, et al.
Publicado: (2021)

P02.147. Emotions matter: sustained reductions in chronic non-structural pain after a brief, manualized emotional processing program
por: Schubiner, H, et al.
Publicado: (2012)

P147 Solriamfetol Titration & AdministRaTion (START): Characteristics of patients with obstructive sleep apnoea (OSA) and prescriber rationale for starting treatment with solriamfetol
por: Singh, H, et al.
Publicado: (2021)

P-159: Effectiveness of anti-SARS-CoV-2 vaccine “booster” dose in patients with multiple myeloma
por: Sgherza, Nicola, et al.
Publicado: (2022)

AB147. Testing questionnaire UIPE for diagnosing premature ejaculation
por: Makhmudov, Azamjon Talatovich, et al.
Publicado: (2015)

P-144: Response to SARS-CoV-2 vaccination in patients with Multiple Myeloma using a 12-week spaced dosing strategy
por: Bird, Sarah, et al.
Publicado: (2021)

P01.15. Multiple Myeloma, chemotherapy and curcumin
por: Panutich, E, et al.
Publicado: (2012)

P-130: The impact of COVID-19 on the treatment regimens of myeloma and AL amyloidosis patients
por: Joyner, Katie, et al.
Publicado: (2021)

P-137: COVID – 19 vaccine uptake in patients with multiple myeloma and AL amyloidosis: a crosssectional observational study from India
por: Ganju, Prabhat, et al.
Publicado: (2022)

A147 “ALREADY GLUTEN-FREE”: A CASE REPORT AND INTERNAL REVIEW OF CHALLENGES IN THE DIAGNOSTIC WORK-UP FOR CHILDREN WITH CELIAC DISEASE
por: Lepore, N, et al.
Publicado: (2023)

P-162: Validation of the second revision of the international staging system in a real-world myeloma population: a myeloma and related diseases registry study
por: Tan, Joanne, et al.
Publicado: (2022)

P-127: Patients with Multiple Myeloma on treatment with Anti-CD38 or Anti-BCMA agents have a suboptimal humoral response following COVID-19 vaccination
por: Terpos, Evangelos, et al.
Publicado: (2021)

P-207: Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myeloma
por: Charalampous, Charalampos, et al.
Publicado: (2022)

P-160: Disparities in multiple myeloma between hispanics and non-hispanics – real world outcomes
por: Shaikh, Hira, et al.
Publicado: (2022)

Low-dose primaquine to reduce the transmission of P. falciparum malaria: a roadmap update
por: Chen, Ingrid, et al.
Publicado: (2014)

An imaging review of extramedullary myeloma
por: Kay, M, et al.
Publicado: (2015)

P12: TREATMENTS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: RETROSPECTIVE CHART REVIEW OF REAL-WORLD OUTCOMES FOR STANDARD OF CARE
por: Vekemans, M-C, et al.
Publicado: (2022)

NP-114: Lesson Learned: Management of patients with Multiple Myeloma (MM) and their response to two doses of COVID-19 RNA vaccine
por: Verina, Daniel, et al.
Publicado: (2021)

P-208: Association of thrombocytopenia with disease burden, high-risk cytogenetics, and survival in newly diagnosed multiple myeloma patients
por: Charalampous, Charalampos, et al.
Publicado: (2022)

Selective pulmonary venous flow visualization and quantification by flow-sensitive four-dimensional cine magnetic resonance imaging facilitates and improves the accurate diagnosis of partial anomalous pulmonary venous drainage
por: Nordmeyer, Sarah, et al.
Publicado: (2011)

Four-dimensional velocity encoded magnetic resonance imaging for more accurate blood flow quantification in complex flow
por: Nordmeyer, Sarah, et al.
Publicado: (2011)

Stimulation of antiviral cellular immune responses by therapeutic vaccination of HIV-1-infected patients with dendritic cells transfected with gag, tat, rev and nef mRNA
por: Van Gulck, Ellen, et al.
Publicado: (2011)

Genome-wide nucleosome mapping in multiple myeloma
por: Small, Eliza C, et al.
Publicado: (2013)

P-115: Unc-51 Like Kinase 3 protein (ULK3)-mediated autophagy is responsible for multiple myeloma resistance to chemotherapy
por: Tauro, Marilena, et al.
Publicado: (2022)

P-161: Oral antivirals ritonavir-nirmatrelvir and molnupiravir are highly effective in patients with multiple myeloma and COVID-19; a singlecenter, prospective study
por: Spiliopoulou, Vassiliki, et al.
Publicado: (2022)

P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
por: Mark, D, et al.
Publicado: (2009)

Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma
por: Łacina, Piotr, et al.
Publicado: (2022)

P131: REAL-TIME VACCINATION IMPACTS IN SICKLE CELL DISEASE: A REAL-WORLD PATIENT CASE STUDY FOR INFLUENZA AND COVID-19 VACCINATION
por: Agrippa, O, et al.
Publicado: (2022)

Emicizumab in acquired haemophilia A: about two clinical cases and literature review
por: Hansenne, Amandine, et al.
Publicado: (2021)

P147 Interaction effects between covid-19 outbreak and community income levels on excess mortality among patients visiting emergency department
por: Jung, Eujene, et al.
Publicado: (2022)

P17-14. Fitness-informed HIV-1 Gag-p24 vaccine design
por: Rolland, MM, et al.
Publicado: (2009)

147. Antibiotic Prescribing: Shorter is Also Better in the Emergency Department
por: Vuong, Lisa, et al.
Publicado: (2021)

Cytogenetic and interphase Fluorescence in Situ Hybridization studies in patients with multiple myeloma
por: Perumal, G, et al.
Publicado: (2014)

P15-14. Assuring data quality of the phase III vaccine trial of ALVAC vaccine priming and AIDSVAX vaccine boosting in Thailand
por: Kaewkungwal, J, et al.
Publicado: (2009)

P19-36. Preclinical study of CombiHIVvac vaccine
por: Kaplina, O, et al.
Publicado: (2009)

P55. Dendritic cell vaccination for postremission therapy in AML
por: Lichtenegger, FS, et al.
Publicado: (2014)

COVID-19, impact on myeloma patients
por: Dufour, Inès, et al.
Publicado: (2020)

Combination of NK cells therapy and oral administration of entinostat as an approach for osteosarcoma lung metastasis treatment
por: Kiany, Simin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t5l3jus9uk7sqgv51i80kamd9t